Loading
EB
Enumeral Biomedical Holdings, Inc. Stock: price and insider trades · United States
Enumeral Biomedical Holdings, Inc.: what insiders have been doing
Insider filings for Enumeral Biomedical Holdings, Inc. are scarce in the SEC (Form 4) feed, the latest one published on 6 January 2016. This page will fill in as new trades are disclosed. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Last declaration on 6 January 2016
Declarations2 total
45,455 sharesCommon StockSEC:0001615774-16-003816:0
95,455 sharesCommon StockSEC:0001615774-16-003822:0
2 of 2 declarations
About Enumeral Biomedical Holdings, Inc.
Enumeral Biomedical Holdings, Inc. is a company focused on developing immunotherapy treatments for cancer. It utilizes advanced technologies to identify and develop drugs targeting the immune system.
